TrialCNS drugs2025

Clinically Meaningful Reduction in Drop Seizures in Patients with Lennox-Gastaut Syndrome Treated with Cannabidiol: Post Hoc Analysis of Phase 3 Clinical Trials.

Nicola Specchio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.